Otomobiltamir
Earth & Environment Science

Research Integrity Roundup: Retractions, AI Peer Review and Scientific Sleuths

Published Nov 07, 2026 Reads 406 By Retraction Watch Staff

A week of major retractions and debates over AI, authorship and research oversight shows how integrity questions are widening across science.

Research Integrity Roundup: Retractions, AI Peer Review and Scientific Sleuths

Research integrity is being tested on several fronts at once: large batches of retractions, questions about who gets credit for scientific work, and AI systems that may change how papers are produced and reviewed. This week’s reporting and research put those pressures into view.

Retractions and accountability

Retraction Watch’s coverage included a computing journal’s withdrawal of 13 papers, four linked to a former editor-in-chief; Bioengineered’s retraction of 119 additional papers as an investigation continues; and a year-long failure by a Springer Nature journal to correct a paper containing a fabricated reference to a Retraction Watch cofounder. A U.S. university also asked a journal to remove a professor’s name from a paper coauthored with a researcher in China.

The monitoring work behind these stories is growing. The Hijacked Journal Checker now lists more than 450 entries, the Retraction Watch Database contains over 68,000 retractions, the COVID-19 retractions list is nearing 800, and the mass resignations list has more than 50 entries. Retraction Watch invites readers to support its work.

AI puts authorship and review under pressure

Debate about AI in publishing is shifting from whether researchers use these tools to how their work should be judged and credited. Researchers argue that AI-assisted article review can outperform human reviewers at their best, while journal editor Karthik Duraisamy offers an uneasy forecast: “pre-submission AI review becomes normal, then expected, then required.” A survey finds that medical journal peer reviewers are familiar with chatbots, though reported use during peer review remains limited.

Other contributions ask whether AI can generate plausible papers faster than detection and peer review can respond, and whether hallucinated references should count as research misconduct. One analysis warns that systems shaped by publishing incentives may optimize for publishability rather than truth, producing work that sounds coherent but lacks empirical grounding. Researchers are also examining disclosure standards for AI-generated images, authorship in generative AI and gaps in consensus around AI policy. An accompanying editorial cautions that agreement alone doesn’t show a policy is appropriate, effective or proportionate.

Institutions, incentives and the record of science

Several stories focus on the structures around research: who can raise concerns, how institutions investigate them and what academic prestige rewards. A panel argues that libraries could help create clearer routes for reporting integrity concerns. Research on editorial mutinies considers what resignations reveal about academic status, while a separate analysis weighs transparency against ethical principles in misconduct investigations.

The journal article itself is also under scrutiny. Commentators question whether its fixed format serves current research, and an essay argues that the article’s status as science’s central currency is weakening. Other work examines conflicts of interest in scientific writing, including a study of nicotine-replacement researchers with ties to manufacturers. Disclosure notices, one critique argues, don’t by themselves shield scholarship from corporate influence.

Trials, trust and scientific correction

In China, a surge of controversial clinical trials is slowing after patient deaths, including a case first reported by Retraction Watch. Other coverage tracks a researcher being impersonated again and a dispute in which a Cell Press inquiry cleared an editor while a Chinese biologist continued to press the matter. A BBC podcast also looks at Retraction Watch and its Ctrl Z Award.

Elsewhere, researchers have described how they debunked “race science,” calling the effort “a triumph of scientific self-correction.” A study suggests that fossils of dinosaurs, mammals and other familiar species appear disproportionately often in high-profile journals. And a health study’s flaws have prompted a personal account asking whether one family paid a price.

Other items include a report that the FDA is enforcing clinical trial result transparency; an article about the continued publication of papers by Putin’s sanctioned daughters in Western journals; and a discussion of the implications of a dismissal of Francesca Gino’s contract and discrimination claims against Harvard Business School.

Upcoming discussion

The 2026 Council of Science Editors Fall Virtual Symposium will feature Retraction Watch cofounder Ivan Oransky in a November 19 session, “Rethinking Incentives to Publish: Aligning Accountability Across Stakeholders.”


Support Retraction Watch with a tax-deductible contribution. Follow the organization on X, on Bluesky, on Facebook or on LinkedIn; add its RSS feed or subscribe to the daily digest. To report a retraction missing from the database, send a tip. Comments and feedback can be sent to [email protected].



Support Retraction Watch with a tax-deductible contribution. Follow the organization on X, on Bluesky, on Facebook or on LinkedIn; add its RSS feed or subscribe to the daily digest. To report a retraction missing from the database, send a tip. Comments and feedback can be sent to [email protected].


Source: Retraction Watch Staff · retractionwatch.com

Discussion

Sign in to join the discussion.